Condition
Qt Interval
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05822076Completed
Influence of Thoracic Paravertebral Block on Cardiac Repolarization
NCT05243537UnknownPrimary
QTc Intervals in Former Preterm/Extreme Low Birth Weight Infants: a Pooled Study Proposal
NCT05225779Not ApplicableUnknown
The Effects of Sevoflurane and Desflurane on QT Interval Measured With Cardiac Electrophysiological Balance Index
NCT02155205Phase 1CompletedPrimary
A Thorough QT Study of Telotristat Etiprate
Showing all 4 trials